Daily Papers

Therapeutic development is a costly and high-risk endeavor that is often plagued by high failure rates. To address this, we introduce TxGemma, a suite of efficient, generalist large language models (LLMs) capable of therapeutic property prediction as well as interactive reasoning and explainability. Unlike task-specific models, TxGemma synthesizes information from diverse sources, enabling broad application across the therapeutic development pipeline. The suite includes 2B, 9B, and 27B parameter models, fine-tuned from Gemma-2 on a comprehensive dataset of small molecules, proteins, nucleic acids, diseases, and cell lines. Across 66 therapeutic development tasks, TxGemma achieved superior or comparable performance to the state-of-the-art generalist model on 64 (superior on 45), and against state-of-the-art specialist models on 50 (superior on 26). Fine-tuning TxGemma models on therapeutic downstream tasks, such as clinical trial adverse event prediction, requires less training data than fine-tuning base LLMs, making TxGemma suitable for data-limited applications. Beyond these predictive capabilities, TxGemma features conversational models that bridge the gap between general LLMs and specialized property predictors. These allow scientists to interact in natural language, provide mechanistic reasoning for predictions based on molecular structure, and engage in scientific discussions. Building on this, we further introduce Agentic-Tx, a generalist therapeutic agentic system powered by Gemini 2.5 that reasons, acts, manages diverse workflows, and acquires external domain knowledge. Agentic-Tx surpasses prior leading models on the Humanity's Last Exam benchmark (Chemistry & Biology) with 52.3% relative improvement over o3-mini (high) and 26.7% over o3-mini (high) on GPQA (Chemistry) and excels with improvements of 6.3% (ChemBench-Preference) and 2.4% (ChemBench-Mini) over o3-mini (high).

Decentralized Finance (DeFi) has turned blockchains into financial infrastructure, allowing anyone to trade, lend, and build protocols without intermediaries, but this openness exposes pools of value controlled by code. Within five years, the DeFi ecosystem has lost over 15.75B USD to reported exploits. Many exploits arise from permissionless opportunities that any participant can trigger using only public state and standard interfaces, which we call Anyone-Can-Take (ACT) opportunities. Despite on-chain transparency, postmortem analysis remains slow and manual: investigations start from limited evidence, sometimes only a single transaction hash, and must reconstruct the exploit lifecycle by recovering related transactions, contract code, and state dependencies. We present TxRay, a Large Language Model (LLM) agentic postmortem system that uses tool calls to reconstruct live ACT attacks from limited evidence. Starting from one or more seed transactions, TxRay recovers the exploit lifecycle, derives an evidence-backed root cause, and generates a runnable, self-contained Proof of Concept (PoC) that deterministically reproduces the incident. TxRay self-checks postmortems by encoding incident-specific semantic oracles as executable assertions. To evaluate PoC correctness and quality, we develop PoCEvaluator, an independent agentic execution-and-review evaluator. On 114 incidents from DeFiHackLabs, TxRay produces an expert-aligned root cause and an executable PoC for 105 incidents, achieving 92.11% end-to-end reproduction. Under PoCEvaluator, 98.1% of TxRay PoCs avoid hard-coding attacker addresses, a +22.9pp lift over DeFiHackLabs. In a live deployment, TxRay delivers validated root causes in 40 minutes and PoCs in 59 minutes at median latency. TxRay's oracle-validated PoCs enable attack imitation, improving coverage by 15.6% and 65.5% over STING and APE.